Alexandra Malinovska

Dr. Alexandra Malinovska

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2017 in European Journal of Internal Medicine
Verified
Journal Article
Closed access
RBRoland Bingisser
Roland Bingisser
MDM. Dietrich
M. Dietrich
ROR. Nieves Ortega
R. Nieves Ortega
AMAlexandra Malinovska
Alexandra Malinovska
TBT. Bosia
T. Bosia
CNC.H. Nickel
C.H. Nickel

18 January 2023 in Chest
Verified
Journal Article
Open access
AMAlexandra Malinovska
Alexandra Malinovska
BHBenjamin Hernried
Benjamin Hernried
ALAndrew Lin
Andrew Lin
OBOluwakemi Badaki-Makun
Oluwakemi Badaki-Makun
KFKatherine Fenstermacher
Katherine Fenstermacher
JHJeremiah S. Hinson
Jeremiah S. Hinson
Monocyte distribution width (MDW) is an emerging biomarker for infection. It is available easily and quickly as part of the CBC count, which is performed routinely on hospital admission. The increasing availability and promising results of MDW as a biomarker in sepsis has prompted an expansion of its use to other infectious diseases. What is the diagnostic performance of MDW across multiple infectious disease outcomes and care settings? A systematic review of the diagnostic performance of MDW across multiple infectious disease outcomes was conducted by searching PubMed, Embase, Scopus, and Web of Science through February 4, 2022. Meta-analysis was performed for outcomes with three or more reports identified (sepsis and COVID-19). Diagnostic performance measures were calculated for individual studies with pooled estimates created by linear mixed-effects models. We identified 29 studies meeting inclusion criteria. Most examined sepsis (19 studies) and COVID-19 (six studies). Pooled estimates of diagnostic performance for sepsis differed by reference standard (Second vs Third International Consensus Definitions for Sepsis and Septic Shock criteria) and tube anticoagulant used and ranged from an area under the receiver operating characteristic curve (AUC) of 0.74 to 0.94, with mean sensitivity of 0.69 to 0.79 and mean specificity of 0.57 to 0.86. For COVID-19, the pooled AUC of MDW was 0.76, mean sensitivity was 0.79, and mean specificity was 0.59. MDW exhibited good diagnostic performance for sepsis and COVID-19. Diagnostic thresholds for sepsis should be chosen with consideration of reference standard and tube type used. Prospero; No.: CRD42020210074; URL: https://www.crd.york.ac.uk/prospero/.

25 March 2020 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
IOIsabelle Osterwalder
Isabelle Osterwalder
MÖMerve Özkan
Merve Özkan
AMAlexandra Malinovska
Alexandra Malinovska
CNChristian Hans Nickel
Christian Hans Nickel
RBRoland Bingisser
Roland Bingisser
Abdominal pain (AP) is a common reason for presentation to an emergency department (ED). With this prospective, observational all-comer study, we aimed to answer three questions: Which diagnoses are most often missed? What is the incidence of extra-abdominal causes? What is the prognosis of abdominal pain in a tertiary urban European ED? Participants were systematically interviewed for the presence of 35 predefined symptoms. For all patients with abdominal pain, the index visit diagnoses were recorded. Related representation was defined as any representation, investigation, or surgery related to the index visit (open time frame). If a diagnosis changed between index visit and representation, it was classified as missed diagnosis. Among 3960 screened presentations, 480 (12.1%) were due to AP. Among 63 (13.1%) related representations, the most prevalent causes were cholelithiasis, gastroenteritis, and urinary retention. A missed diagnosis was attributed to 27 (5.6%) presentations. Extra-abdominal causes were identified in 162 (43%) presentations. Thirty-day mortality was comparable to that of all other ED patients (2.2% vs. 2.1%). Patients with abdominal pain had a low risk of representation, and the majority of representations due to missed diagnoses were of benign origin. The high incidence of extra-abdominal causes is noteworthy, as this may induce change to differential diagnosis of abdominal pain.

15 January 2013 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
BSBenjamin Joachim Schmiedel
Benjamin Joachim Schmiedel
TNTina Nuebling
Tina Nuebling
JSJulia Steinbacher
Julia Steinbacher
AMAlexandra Malinovska
Alexandra Malinovska
CWConstantin Maximilian Wende
Constantin Maximilian Wende
HSHelmut Rainer Salih
Helmut Rainer Salih
The TNF family member receptor activator for NF-κB ligand (RANKL) and its receptors RANK and osteoprotegerin are key regulators of bone remodeling but also influence cellular functions of tumor and immune effector cells. In this work, we studied the involvement of RANK–RANKL interaction in NK cell–mediated immunosurveillance of acute myeloid leukemia (AML). Substantial levels of RANKL were found to be expressed on leukemia cells in 53 of 78 (68%) investigated patients. Signaling via RANKL into the leukemia cells stimulated their metabolic activity and induced the release of cytokines involved in AML pathophysiology. In addition, the immunomodulatory factors released by AML cells upon RANKL signaling impaired the anti-leukemia reactivity of NK cells and induced RANK expression, and NK cells of AML patients displayed significantly upregulated RANK expression compared with healthy controls. Treatment of AML cells with the clinically available RANKL Ab Denosumab resulted in enhanced NK cell anti-leukemia reactivity. This was due to both blockade of the release of NK-inhibitory factors by AML cells and prevention of RANK signaling into NK cells. The latter was found to directly impair NK anti-leukemia reactivity with a more pronounced effect on IFN-γ production compared with cytotoxicity. Together, our data unravel a previously unknown function of the RANK–RANKL molecule system in AML pathophysiology as well as NK cell function and suggest that neutralization of RANKL with therapeutic Abs may serve to reinforce NK cell reactivity in leukemia patients.

20 November 2018 in Breast Cancer Research
Verified
Journal Article
Open access
PDF file
MVMarcus Vetter
Marcus Vetter
JLJulia Landin
Julia Landin
BSBarbara Maria Szczerba
Barbara Maria Szczerba
FCFrancesc Castro-Giner
Francesc Castro-Giner
SGSofia Gkountela
Sofia Gkountela
NANicola Aceto
Nicola Aceto
The presence of circulating tumor cells (CTCs) in patients with breast cancer correlates to a bad prognosis. Yet, CTCs are detectable in only a minority of patients with progressive breast cancer, and factors that influence the abundance of CTCs remain elusive. We conducted CTC isolation and enumeration in a selected group of 73 consecutive patients characterized by progressive invasive breast cancer, high tumor load and treatment discontinuation at the time of CTC isolation. CTCs were quantified with the Parsortix microfluidic device. Clinicopathological variables, blood counts at the time of CTC isolation and detailed treatment history prior to blood sampling were evaluated for each patient. Among 73 patients, we detected at least one CTC per 7.5 ml of blood in 34 (46%). Of these, 22 (65%) had single CTCs only, whereas 12 (35%) featured both single CTCs and CTC clusters. Treatment with the monoclonal antibody denosumab correlated with the absence of CTCs, both when considering all patients and when considering only those with bone metastasis. We also found that low red blood cell count was associated with the presence of CTCs, whereas high CA 15-3 tumor marker, high mean corpuscular volume, high white blood cell count and high mean platelet volume associated specifically with CTC clusters. In addition to blood count correlatives to single and clustered CTCs, we found that denosumab treatment associates with most patients lacking CTCs from their peripheral circulation. Prospective studies will be needed to validate the involvement of denosumab in the prevention of CTC generation.

10 July 2018 in European Journal of Internal Medicine
Verified
Journal Article
Closed access
PDF file
AMAlexandra Malinovska
Alexandra Malinovska
CNChristian H. Nickel
Christian H. Nickel
RBRoland Bingisser
Roland Bingisser